Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ligand Design. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110746448A introduces a novel chiral 1,2-ethylenediamine boron-nitrogen ligand. This technology enables cost reduction in asymmetric catalysis manufacturing and ensures high-purity pharmaceutical intermediates.
Patent CN114478632B reveals high-ee chiral ligands for hydroformylation. Enhance supply chain reliability and reduce manufacturing costs with scalable synthesis.
Patent CN113980053A discloses novel chiral thioether-phosphine ligands enabling efficient palladium-catalyzed asymmetric allylic alkylation with high yields.
Patent CN116178431A discloses advanced N,N,P ligands enabling high enantioselectivity in radical reactions. Discover cost-effective synthesis and supply chain advantages for pharma intermediates.
Patent CN103483267A discloses a versatile arylimidazole catalyst enabling high-yield, glove-box-free synthesis of chiral alpha-amino boronic acid intermediates.
Patent CN103804413A reveals a novel biphenyl triphosphine ligand synthesis enhancing hydroformylation selectivity and offering significant cost reduction in fine chemical manufacturing.
Novel pyridine-amide-oxazoline ligands for asymmetric hydroboration. High yield synthesis over 80 percent. Reliable supplier for pharma intermediates.
Patent CN1791607A details novel chiral ligands enabling high enantioselectivity. Discover cost-effective manufacturing and scalable supply solutions for pharmaceutical intermediates.
High-purity chiral ligands and metal complexes for asymmetric synthesis. Efficient routes for pharmaceutical intermediates with superior enantioselectivity.
Patent CN1374935A reveals advanced multidentate phosphite ligands enhancing hydroformylation selectivity. Discover cost-effective catalytic solutions for aldehyde manufacturing.
Discover advanced biphenyl tridentate phosphite ligands from patent CN111848683A. Enhance hydroformylation efficiency and reduce costs in plasticizer intermediate manufacturing.
Novel chiral thioether-phosphine compounds for Pd-catalyzed asymmetric allylic alkylation. Efficient synthesis, high yield, reliable supply chain for pharmaceutical intermediates.
Patent CN108409802B details a high-efficiency iridium-catalyzed asymmetric hydrogenation route for producing high-purity chiral ferrocene amines with significant cost advantages.
Patent CN1098856C discloses novel chiral amidophosphine trivalent phosphonate ligands enabling high-efficiency asymmetric hydrogenation for pharmaceutical and fine chemical manufacturing.
Patent CN100349905C discloses novel Tropp ligands enabling high-efficiency asymmetric hydrogenation. Discover supply chain advantages and technical feasibility.
Patent CN113024615A discloses efficient chiral ligands enabling cheap metal catalysis for API synthesis, offering significant cost reduction and supply chain stability.
Explore the novel synthesis of chiral oxazoline-zinc complexes via patent CN102212078A, offering robust catalytic solutions and supply chain stability for pharmaceutical manufacturing.
Patent CN113999261B reveals a high-yield synthesis for ortho-dimethyl diphosphine ligands, offering cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Patent CN101395165A discloses a high-efficiency asymmetric ligand enabling cost reduction in pharmaceutical intermediate manufacturing with superior enantioselectivity.
Patent CN102464672A discloses a novel mannitol-based ligand for asymmetric catalysis, offering high enantioselectivity and simplified synthesis for cost-effective pharmaceutical manufacturing.